Close Menu
AI Week
  • Breaking
  • Insight
  • Ethics & Society
  • Innovation
  • Education and Training
  • Spotlight
Trending

UN experts warn against market-driven AI development amid global concerns

September 20, 2024

IBM launches free AI training programme with skill credential in just 10 hours

September 20, 2024

GamesBeat Next 2023: Emerging leaders in video game industry to convene in San Francisco

September 20, 2024
Facebook X (Twitter) Instagram
Newsletter
  • Privacy
  • Terms
  • Contact
Facebook X (Twitter) Instagram YouTube
AI Week
Noah AI Newsletter
  • Breaking
  • Insight
  • Ethics & Society
  • Innovation
  • Education and Training
  • Spotlight
AI Week
  • Breaking
  • Insight
  • Ethics & Society
  • Innovation
  • Education and Training
  • Spotlight
Home»Innovation»Hoth Therapeutics and Wise Systems International Collaborate to Enhance Drug Discovery with AI
Innovation

Hoth Therapeutics and Wise Systems International Collaborate to Enhance Drug Discovery with AI

Ivan MassowBy Ivan MassowJune 10, 20241 ViewsNo Comments3 Mins Read
Share
Facebook Twitter LinkedIn WhatsApp Email

Hoth Therapeutics partners with Wise Systems International to leverage AI technology, specifically Nvidia’s BioNeMo platform, aiming to accelerate drug discovery processes and deliver novel therapeutics. This collaboration reflects a growing trend of tech-biopharma partnerships in the industry.

Hoth Therapeutics and Wise Systems International to Collaborate on AI-driven Drug Discovery

New York, June 10, 2024 — Hoth Therapeutics, Inc., a biopharmaceutical organisation listed on NASDAQ, announced a joint development agreement with Wise Systems International SRL. The collaboration aims to enhance drug discovery processes through the utilisation of artificial intelligence, specifically leveraging Nvidia’s BioNeMo AI platform.

The BioNeMo generative AI platform is designed to aid researchers and developers in creating and integrating advanced AI applications across the spectrum of drug discovery activities. This includes stages such as target identification and lead optimisation, made possible through AI-based workflows. According to the agreement, Wise Systems International (SRL) will assist Hoth Therapeutics in employing this AI technology to expand and refine its therapeutic pipeline.

Robert Antofe from Wise Systems International highlighted the potential benefits of the partnership, expressing enthusiasm about the opportunity to apply their AI expertise to contribute to both companies’ growth in the pharmaceutical sector.

Robb Knie, Chief Executive Officer of Hoth Therapeutics, remarked on the potential of Nvidia’s BioNeMo platform. “We believe it is best in class,” Knie stated. “With SRL’s assistance, we anticipate significant advancements in our intellectual property and pipeline, ultimately striving to deliver novel therapeutics to patients.”

This collaboration is seen as a strategic move for Hoth Therapeutics, a company known for its patient-focused approach in the biopharmaceutical industry. The company specialises in early-stage pharmaceutical research, pushing drugs from the discovery phase through to pre-clinical and clinical testing. By integrating cutting-edge AI technologies, Hoth Therapeutics aims to accelerate the drug discovery process, potentially leading to more efficient development of treatments that could improve patient outcomes.

Wise Systems International SRL, on the other hand, brings its AI expertise to the table, complementing Hoth Therapeutics’ pharmaceutical focus. This partnership aligns with broader trends in the industry where AI is increasingly being used to streamline and enhance drug discovery processes. The use of AI technologies, such as Nvidia’s BioNeMo, is seen as a promising tool in handling the complexities and vast data sets involved in pharmaceutical research.

Hoth Therapeutics’ announcement follows a growing trend of collaborations between technology firms and biopharmaceutical companies, aiming to harness the power of AI to revolutionise healthcare and drug development. With the increasing capabilities of AI, such collaborations are expected to bring about more rapid and cost-effective advancements in medical research.

For further information on Hoth Therapeutics, their research initiatives, and ongoing projects, interested parties can visit their official website.

Contacts:
– Investor Relations: LR Advisors LLC, [email: inv[email protected]], [website: www.hoththerapeutics.com], [phone: (678) 570-6791]

This article is based on an announcement made by Hoth Therapeutics, Inc. and aims to present an objective overview of the strategic collaboration between Hoth Therapeutics and Wise Systems International SRL, placing it within the broader context of trends in biopharmaceutical research and artificial intelligence.

Innovation Spotlight
Share. Facebook Twitter LinkedIn Telegram WhatsApp Email Copy Link
Ivan Massow
  • X (Twitter)

Ivan Massow Senior Editor at AI WEEK, Ivan, a life long entrepreneur, has worked at Cambridge University's Judge Business School and the Whittle Lab, nurturing talent and transforming innovative technologies into successful ventures.

Related News

UN experts warn against market-driven AI development amid global concerns

September 20, 2024

IBM launches free AI training programme with skill credential in just 10 hours

September 20, 2024

GamesBeat Next 2023: Emerging leaders in video game industry to convene in San Francisco

September 20, 2024

Alibaba Cloud unveils cutting-edge modular datacentre technology at annual Apsara conference

September 20, 2024

Dentistry.One unveils innovative SmileScan AI tool for oral health monitoring

September 20, 2024

Inbolt secures €15 million in Series A round to propel expansion and technological advancements

September 20, 2024
Add A Comment
Leave A Reply Cancel Reply

Top Articles

IBM launches free AI training programme with skill credential in just 10 hours

September 20, 2024

GamesBeat Next 2023: Emerging leaders in video game industry to convene in San Francisco

September 20, 2024

Alibaba Cloud unveils cutting-edge modular datacentre technology at annual Apsara conference

September 20, 2024

Subscribe to Updates

Get the latest AI news and updates directly to your inbox.

Advertisement
Demo
AI Week
Facebook X (Twitter) Instagram YouTube
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 AI Week. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.